Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Diclofenac Sodium Gel in Knee Osteoarthritis
NCT00171691Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Jun 2006
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Voltaren gel in osteoarthritis (OA), sponsored by Novartis. Primary endpoints: Incidence of treatment-emergent adverse events at 12 months and Number of laboratory values outside pre-determined ranges at 12 months. Started Oct 2004; status: completed.
02
Drugs
Voltaren gel
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00171691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171691.